Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica

References

• Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261–71.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Sunku J, Salvarani C, O'Fallon WM, Hunder GG. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997;40:1873–8.
   PubMed Web of Science ®Google Scholar
• Mikines KJ, Richter EA, Dela F, Galbo H. Seven days of bed rest decrease insulin action on glucose uptake in leg and whole body. J Appl Physiol 1991;70:1245–54.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7.
   PubMed Web of Science ®Google Scholar
• Dessein PH, Joffe BI, Stanwix AE, Christian BF, Veller M. Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol 2004;31:867–74.
   PubMed Web of Science ®Google Scholar
• Tam LS, Tomlinson B, Chu TT, Li TK, Li EK. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:1495–8.
   PubMed Web of Science ®Google Scholar
• Sivalingam SP, Thumboo J, Vasoo S, Thio ST, Tse C, Fong KY. In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singapore 2007;36:96–9.
   PubMed Web of Science ®Google Scholar
• Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1198–201.
   PubMed Web of Science ®Google Scholar
• Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006;54:2765–75.
   PubMed Web of Science ®Google Scholar
• Tappy L, Randin D, Vollenweider P, Vollenweider L, Paquot N, Scherrer U, Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 1994;79:1063–9.
   PubMed Web of Science ®Google Scholar
• Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 1993;91:2020–30.
   PubMed Web of Science ®Google Scholar
• Svenson KL, Pollare T, Lithell H, Hallgren R. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism 1988;37:125–30.
   PubMed Web of Science ®Google Scholar
• Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Avalos I, Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 2008;58:2105–12.
   PubMed Web of Science ®Google Scholar
• Pemberton PW, Ahmad Y, Bodill H, Lokko D, Hider SL, Yates AP, Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis. BMC Res Notes 2009;2:83.
   PubMedGoogle Scholar
• Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672–80.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–70.
   PubMed Web of Science ®Google Scholar
• Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008;121:S21–31.
   PubMed Web of Science ®Google Scholar
• Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 1997;100:2094–8.
   PubMed Web of Science ®Google Scholar
• Zonana-Nacach A, Santana-Sahagun E, Jimenez-Balderas FJ, Camargo-Coronel A. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. J Clin Rheumatol 2008;14:74–7.
   PubMed Web of Science ®Google Scholar
• Korczowska I, Olewicz-Gawlik A, Trefler J, Hrycaj P, Krzysztof Lacki J. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients? Clin Rheumatol 2008;27:565–72.
   PubMed Web of Science ®Google Scholar
• Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of training on the dose–response relationship for insulin action in men. J Appl Physiol 1989;66:695–703.
   PubMed Web of Science ®Google Scholar
• Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol 1988;254:E248–59.
   PubMed Web of Science ®Google Scholar
• Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286–94.
   PubMed Web of Science ®Google Scholar
• Uddhammar A, Sundqvist KG, Ellis B, Rantapaa-Dahlqvist S. Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Br J Rheumatol 1998;37:766–9.
   PubMedGoogle Scholar
• Sulli A, Montecucco CM, Caporali R, Cavagna L, Montagna P, Capellino S, Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis. Ann N Y Acad Sci 2006;1069:307–14.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Montecucco CM, Cavagna L, Caporali R, Capellino S, Montagna P, Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006;65:1438–43.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Niccoli L, Catanoso MG, Macchioni P, Pulsatelli L, Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol 2003;30:760–3.
   PubMed Web of Science ®Google Scholar
• Migliore A, Massafra U, Carloni E, Padalino C, Martin Martin S, Lasaracina F, TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report. Eur Rev Med Pharmacol Sci 2005;9:373–8.
   PubMedGoogle Scholar
• Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 2007;146:631–9.
   PubMed Web of Science ®Google Scholar
• Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 1999;163:1521–8.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994;91:4854–8.
   PubMed Web of Science ®Google Scholar
• Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003;278:45777–84.
   PubMed Web of Science ®Google Scholar
• Oguz FM, Oguz A, Uzunlulu M. The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis. Acta Clin Belg 2007;62:218–22.
   PubMed Web of Science ®Google Scholar
• Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006;24:529–33.
   PubMed Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356–61.
   PubMed Web of Science ®Google Scholar
• Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 2003;148:535–42.
   PubMed Web of Science ®Google Scholar
• Sell H, Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol 2007;18:258–62.
   PubMed Web of Science ®Google Scholar
• Pulsatelli L, Meliconi R, Boiardi L, Macchioni P, Salvarani C, Facchini A. Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1998;16:263–8.
   PubMed Web of Science ®Google Scholar
• Ellingsen T, Elling P, Olson A, Elling H, Baandrup U, Matsushima K, Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica. Ann Rheum Dis 2000;59:775–80.
   PubMed Web of Science ®Google Scholar
• Lihn AS, Richelsen B, Pedersen SB, Haugaard SB, Rathje GS, Madsbad S, Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003;285:E1072–80.
   PubMed Web of Science ®Google Scholar
• Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094–9.
   PubMed Web of Science ®Google Scholar
• Beltowski J. Adiponectin and resistin – new hormones of white adipose tissue. Med Sci Monit 2003;9:RA55–61.
   PubMedGoogle Scholar
• Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26:2442–50.
   PubMed Web of Science ®Google Scholar
• Jang C, Inder WJ, Obeyesekere VR, Alford FP. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clin Endocrinol (Oxf) 2008;69:745–50.
   PubMed Web of Science ®Google Scholar
• Ehling A, Schaffler A, Herfarth H, Tarner IH, Anders S, Distler O, The potential of adiponectin in driving arthritis. J Immunol 2006;176:4468–78.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 2008;121:326–30.
   PubMed Web of Science ®Google Scholar
• Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol 2008;35:936–8.
   PubMed Web of Science ®Google Scholar
• Harle P, Sarzi-Puttini P, Cutolo M, Straub RH. No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:970–1.
   PubMedGoogle Scholar
• Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 2005;64:1195–8.
   PubMed Web of Science ®Google Scholar
• Bruder ED, Jacobson L, Raff H. Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia. J Endocrinol 2005;185:477–84.
   PubMed Web of Science ®Google Scholar
• Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997;272:10585–93.
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, The hormone resistin links obesity to diabetes. Nature 2001;409:307–12.
   PubMed Web of Science ®Google Scholar